The DOI matches its Crossref record.
Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients
Open accessAbstract
This article contains highlights of “Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients: Recommendations of the CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation,” which was published in the Morbidity and Mortality Weekly Report. There are sections on the prevention of bacterial, viral, fungal, protozoal, and helminth infections and on hospital infection control, strategies for safe living following transplantation, immunizations, and hematopoietic stem cell safety. The guidelines are evidence-based, and prevention strategies are rated by both the strength of the recommendation and the quality of evidence that supports it. Recommendations are given for preventing cytomegalovirus disease with prophylactic or preemptive gancyclovir, herpes simplex virus disease with prophylactic acyclovir, candidiasis with fluconazole, and Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole. Hopefully, following the recommendations made in the guidelines will reduce morbidity and mortality from opportunistic infections in hematopoietic stem cell transplant recipients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 34
- Centers for Disease Control and Prevention, 2000, Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation, MMWR Morb Mortal Wkly Rep, 49, 1
- Centers for Disease Control and Prevention, 1995, USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary, MMWR Morb Mortal Wkly Rep, 44, 1
- Centers for Disease Control and Prevention, 1997, 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, MMWR Morb Mortal Wkly Rep, 46, 1
- Centers for Disease Control and Prevention, 1999, 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, MMWR Morb Mortal Wkly Rep, 48, 1
- Gross, 1994, Purpose of quality standards for infectious diseases, Clin Infect Dis, 18, 421, 10.1093/clinids/18.3.421 · DOI · Paper page
- Kessinger, 1993, The use of peripheral stem cell support of high-dose chemotherapy, 167
- Bowden, 1995, A comparison of filtered leukocyte reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplantation, Blood, 86, 3598, 10.1182/blood.V86.9.3598.bloodjournal8693598 · DOI · Paper page
- Boeckh, 1996, Cytomegalovirus pp65 antigenemia guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double blind study, Blood, 88, 4063, 10.1182/blood.V88.10.4063.bloodjournal88104063 · DOI · Paper page
- Boeckh, 1996, Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation, J Infect Dis, 174, 907, 10.1093/infdis/174.5.907 · doi:10.1093/infdis/174.5.907
- Einsele, 1995, Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effect of antiviral therapy after bone marrow transplantation, Blood, 86, 2815, 10.1182/blood.V86.7.2815.2815 · DOI · Paper page
- Mendez, 1999, Human cytomegalovirus, 361
- Goodrich, 1991, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplant, N Engl J Med, 325, 1601, 10.1056/NEJM199112053252303 · DOI · Paper page
- Schmidt, 1991, A randomized controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants, N Engl J Med, 324, 1005, 10.1056/NEJM199104113241501 · DOI · Paper page
- Goodrich, 1993, Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant, Ann Intern Med, 118, 173, 10.7326/0003-4819-118-3-199302010-00003 · DOI · Paper page
- Saral, 1981, Acyclovir prophylaxis of herpes simplex infections, N Engl J Med, 305, 63, 10.1056/NEJM198107093050202 · DOI · Paper page
- Gluckman, 1983, Prophylaxis of herpes infections after bone marrow transplantation by oral acyclovir, Lancet, 2, 706, 10.1016/S0140-6736(83)92248-1 · doi:10.1016/s0140-6736(83)92248-1
- Wade, 1982, Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation, Ann Intern Med, 96, 265, 10.7326/0003-4819-96-3-265 · DOI · Paper page
- Wade, 1984, Oral acyclovir for prevention of herpes simplex reactivation after marrow transplantation, Ann Intern Med, 100, 823, 10.7326/0003-4819-100-6-823 · DOI · Paper page
- Johnson, 1992, Hepatitis due to herpes simplex virus in marrow-transplant recipients, Clin Infect Dis, 14, 38, 10.1093/clinids/14.1.38 · doi:10.1093/clinids/14.1.38
- Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301 · DOI · Paper page
- Slavin, 1995, Efficacy and safety of fluconazole for fungal infections after marrow transplant: a prospective, randomized, double-blind study, J Infect Dis, 171, 1545, 10.1093/infdis/171.6.1545 · DOI · Paper page
- Opal, 1986, Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction, J Infect Dis, 153, 634, 10.1093/infdis/153.3.634 · DOI · Paper page
- Tuan, 1992, Pneumocystis carinii pneumonitis following bone marrow transplantation, Bone Marrow Transplant, 10, 267
- Castagnola, 1995, Low CD4 count in a patient with P. carinii pneumonia after autologous bone marrow transplantation, Bone Marrow Transplant, 15, 977
- Streifel, 1999, Design and maintenance of hospital ventilation systems and the prevention of airborne nosocomial infections, 1211
- Streifel, 1998, Parameters for ventilation controlled environments in hospitals, 305
- Centers for Disease Control and Prevention, 1994, Guidelines for prevention of nosocomial pneumonia, Respiratory Care, 39, 1191
- The American Institute of Architects Academy of Architecture for Health, with assistance from the US Department of Health and Human Services, 1996, Guidelines for design and construction of hospital and medical facilities, 58
- Rhame, 1984, Extrinsic risk factors for pneumonia in the patient at high risk of infection, Am J Med, 76, 42, 10.1016/0002-9343(84)90243-2 · DOI · Paper page
- Centers for Disease Control and Prevention, 1996, Outbreaks of Salmonella serotype enteritidis infection associated with consumption of raw shell eggs—United States, 1994–1995, MMWR Morb Mortal Wkly Rep, 45, 737
- Centers for Disease Control and Prevention, 1996, Vibrio vulnificus infections associated with eating raw oysters—Los Angeles, 1996, MMWR Morb Mortal Wkly Rep, 45, 621
- Centers for Disease Control and Prevention, 1999, Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound—Connecticut, New Jersey, and New York, 1998, MMWR Morb Mortal Wkly Rep, 48, 48
- Centers for Disease Control and Prevention, 1997, Viral gastroenteritis associated with eating oysters—Louisiana, December 1996-January 1997, MMWR Morb Mortal Wkly Rep, 46, 1109
- Fayer, 1999, Cryptosporidium parvum in oysters from commercial harvesting sites in Chesapeake Bay, Emerg Infect Dis, 5, 706, 10.3201/eid0505.990513 · doi:10.3201/eid0505.990513
Cited by
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Novello, S., Barlesi, F., Califano, R., Cufer, T., Ekman, S., Levra, M. G., Kerr, K., Popat, S., Reck, M., Senan, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw326 · Cited by 2,631
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Planchard, D., Popat, S., Kerr, K., Novello, S., Smit, E. F., Faivre-Finn, C., Mok, T. S., Reck, M., Van Schil, P. E., Hellmann, M. D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy275 · Cited by 2,274
Metadata
- Authors
- Dykewicz, C. A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-07-15
- Volume
- 33
- Issue
- 2
- Pages
- 139-144
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108824619
- Cited by
- 636
- References
- 0
- FWCI
- 4.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. https://app.cochat.ai/papers/10.1086/321805
- The paper
- Dykewicz, C. A. (2001). Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients. Clinical Infectious Diseases. https://doi.org/10.1086/321805
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
